Drugs & TargetsFree Tagrisso receives FDA Breakthrough Therapy Designation for adjuvant treatment of stage IB-IIIA EGFR-mutated lung cancer July 31, 2020Vol.46 No.31
Drugs & TargetsFree Piqray receives approval in Europe for HR+/HER2- advanced breast cancer with a PIK3CA mutation July 31, 2020Vol.46 No.31
Drugs & Targets FDA accepts Karyopharm’s sNDA for Xpovio as a treatment for multiple myeloma after at least one prior line of therapy July 24, 2020Vol.46 No.30
Drugs & Targets FDA issues draft guidance to encourage cannabis-related clinical research July 24, 2020Vol.46 No.30
Drugs & Targets FDA proposes rule on reporting requirement under Right to Try Act July 24, 2020Vol.46 No.30
Drugs & Targets Pfizer and BioNTech receive FDA Fast Track designation for investigational COVID-19 vaccine candidates July 17, 2020Vol.46 No.29
Drugs & Targets Ashion Analytics receives Medicare coverage for assay for advanced solid tumors July 17, 2020Vol.46 No.29
Drugs & Targets Keytruda’s sBLA receives Priority Review from FDA for second-line treatment of relapsed or refractory classical Hodgkin lymphoma July 10, 2020Vol.46 No.28
